AF drug advised for plans Could harmonizing formularies save money?TORONTO | A new study suggests that cash-strapped Ontario could glean some potential savings if hospitals decided to tweak the formularies for chronic medications. Hypoxia predicts prostate cancer recurrence Low tumour oxygenation linked with biochemical relapse within 48 months of treatment Jim Flaherty, mother of invention? The bright side of the new federal funding formula is that it may force the provinces to innovate Journal of pain Melatonin may be helpful for sleep problems in children and adolescents Melatonin can be useful for treating certain sleep problems in children and adolescents, according to a new statement from the Canadian Paediatric Society. Metformin slows prostate cancer growth Small Canadian study measures markers of cell proliferation Partners in translation Why research funding agencies are uniquely placed to encourage knowledge translation Redefining breast cancer After years of studying thousands of tumour samples, researchers in Canada, Britain and Norway have reclassified the disease into 10 new categories Selumetinib shows promise in ovarian cancer Oral MEK inhibitor produces ‘striking’ results in early clinical trial The trouble with Ontario doctors Trials fine-tune treatment of low-risk thyroid cancer Less radioiodine as effective as higher dose, studies show First Previous 1521 1522 1523 1524 1525 Next Last
